Conference Coverage
Conference Coverage
Cardiac Monitoring Is Crucial in Neuromuscular Disorder Care
Cardiac conditions can range from asymptomatic to potentially lethal.
Conference Coverage
ALS Update: Drug Therapy Continues to Offer Little Benefit
There’s “a relatively significant additional benefit” to earlier treatment, although patients will vary on whether they think it’s meaningful.
Conference Coverage
Myasthenia Gravis: Similar Symptoms in Relatives Raise Question of Genes
Conference Coverage
At Last, Treatment Is in Sight for Charcot-Marie-Tooth Disease
Genetic-based therapies are currently in preclinical research phases, and an experimental small-molecule drug has reached phase 3 in humans.
Conference Coverage
Sustained Control with Investigational Monoclonal Antibody for Myasthenia Gravis
The VIVACITY-MG3 trial is the first registrational study of a neonatal fragment crystallizable receptor blocker to show sustained efficacy through...
Conference Coverage
First-in-Class B-Cell Depleting Agent Promising for Myasthenia Gravis
Although inebilizumab is already FDA-approved for the treatment of neuromyelitis optica, it still faces approval and indication hurdles for MG.
Feature
Group Aims to Better Define ‘Extraordinarily Heterogeneous’ Mast Cell Activation Syndrome
There is controversy over the diagnostic criteria, with one proposed definition placing it at the center of many other co-occurring complex,...
Conference Coverage
A New Way to ‘Smuggle’ Drugs Through the Blood-Brain Barrier
Conference Coverage
Is Pimavanserin a Better Option for Parkinson’s Psychosis?
Pimavanserin yielded significant improvement across all parameters of efficacy without worsening motor symptoms and was very well tolerated.
Conference Coverage
sNFl and sGFAP Predict MS Disability in Unique Ways
GFAP might soon join serum neurofilament light chain (sNFl) levels for predicting disability, but each has unique features and they appear to...
Conference Coverage
Autonomy Versus Safety in Cognitive Impairment Decision-Making
As healthcare systems across Europe deal with an increasing prevalence of cognitive impairment, family doctors are...